Hedge Fund - Knoll Capital Management
Anavex Life Sciences Corp. (AVXL)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2022 - Q2 (2022-06-30) | $0 | 0% | 0 | $9.47 |
| 2 | 2022 - Q1 (2022-03-31) | $2,595,000 | 1.62% | 210,789 | $12.30 |
| 3 | 2021 - Q1 (2021-03-31) | $0 | 0% | 0 | $10.92 |
| 4 | 2020 - Q4 (2020-12-31) | $3,622,000 | 2.46% | 670,789 | $5.27 |
| 5 | 2020 - Q3 (2020-09-30) | $2,825,000 | 2.31% | 620,789 | $4.30 |
| 6 | 2020 - Q2 (2020-06-30) | $3,621,000 | 2.09% | 724,205 | $3.78 |
| 7 | 2020 - Q1 (2020-03-31) | $2,281,000 | 2.14% | 724,205 | $3.48 |
| 8 | 2019 - Q4 (2019-12-31) | $1,876,000 | 1.38% | 724,205 | $2.62 |
| 9 | 2019 - Q3 (2019-09-30) | $2,288,000 | 2.09% | 724,205 | $2.89 |
| 10 | 2019 - Q2 (2019-06-30) | $2,441,000 | 1.99% | 724,205 | $3.11 |
| 11 | 2019 - Q1 (2019-03-31) | $2,209,000 | 1.67% | 724,205 | $2.39 |
| 12 | 2018 - Q4 (2018-12-31) | $1,130,000 | 1.28% | 724,205 | $2.27 |
| 13 | 2018 - Q3 (2018-09-30) | $1,868,000 | 1.57% | 724,205 | $2.82 |
| 14 | 2018 - Q2 (2018-06-30) | $1,897,000 | 1.61% | 724,205 | $2.79 |
| 15 | 2018 - Q1 (2018-03-31) | $1,999,000 | 2.05% | 724,205 | $2.83 |
| 16 | 2017 - Q4 (2017-12-31) | $2,332,000 | 2.05% | 724,205 | $3.94 |
| 17 | 2017 - Q3 (2017-09-30) | $2,998,000 | 2.56% | 724,205 | $4.44 |
| 18 | 2017 - Q2 (2017-06-30) | $3,853,000 | 5.1% | 724,205 | $5.78 |
| 19 | 2017 - Q1 (2017-03-31) | $4,157,000 | 6.26% | 724,205 | $5.16 |
| 20 | 2016 - Q4 (2016-12-31) | $2,868,000 | 5.03% | 724,205 | $3.56 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
1.0000:4.0000 on 2015-10-07